Monoclonal antibodies specific for the empty conformation of HLA-DR1 reveal aspects of the conformational change associated with peptide binding

被引:42
|
作者
Carven, GJ
Chitta, S
Hilgert, I
Rushe, MM
Baggio, RF
Palmer, M
Arenas, JE
Strominger, JL
Horejsi, V
Santambrogio, L
Stern, LJ
机构
[1] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA
[2] MIT, Dept Chem, Cambridge, MA 02139 USA
[3] Acad Sci Czech Republ, Inst Genet Mol, CZ-16637 Prague, Czech Republic
[4] Appl Biosyst Cell Biol & Funct Proteom, Bedford, MA 01730 USA
[5] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[6] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[7] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
关键词
D O I
10.1074/jbc.M314315200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Class II major histocompatibility complex (MHC) proteins bind peptides and present them at the cell surface for interaction with CD4(+) T cells as part of the system by which the immune system surveys the body for signs of infection. Peptide binding is known to induce conformational changes in class II MHC proteins on the basis of a variety of hydrodynamic and spectroscopic approaches, but the changes have not been clearly localized within the overall class II MHC structure. To map the peptide-induced conformational change for HLA-DR1, a common human class II MHC variant, we generated a series of monoclonal antibodies recognizing the beta subunit that are specific for the empty conformation. Each antibody reacted with the empty but not the peptide-loaded form, for both soluble recombinant protein and native protein expressed at the cell surface. Antibody binding epitopes were characterized using overlapping peptides and alanine scanning substitutions and were localized to two distinct regions of the protein. The pattern of key residues within the epitopes suggested that the two epitope regions undergo substantial conformational alteration during peptide binding. These results illuminate aspects of the structure of the empty forms and the nature of the peptide-induced conformational change.
引用
收藏
页码:16561 / 16570
页数:10
相关论文
共 50 条
  • [21] T-cell like human monoclonal antibody recognizes MHC class I self peptide presented by HLA-DR1 on activated cells.
    Eiermann, TH
    Woelpl, A
    Halder, T
    Kalbacher, H
    FASEB JOURNAL, 1999, 13 (04) : A274 - A274
  • [22] Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells
    Wölpl, A
    Halder, T
    Kalbacher, H
    Neumeyer, H
    Siemoneit, K
    Goldmann, SF
    Eiermann, TH
    TISSUE ANTIGENS, 1998, 51 (03): : 258 - 269
  • [23] A distinctive peptide binding motif for HLA-DRB1*0407, an HLA-DR4 subtype not associated with rheumatoid arthritis
    M. P. Davenport
    Andrew Godkin
    Thomas Friede
    Stefan Stevanović
    Anthony C. Willis
    Adrian V. S. Hill
    Hans-Georg Rammensee
    Immunogenetics, 1997, 45 : 229 - 232
  • [24] HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen
    Rosloniec, EF
    Whittington, KB
    Zaller, DM
    Kang, AH
    JOURNAL OF IMMUNOLOGY, 2002, 168 (01) : 253 - 259
  • [25] Mapping of Conformational IgE Epitopes with Peptide-Specific Monoclonal Antibodies Reveals Simultaneous Binding of Different IgE Antibodies to a Surface Patch on the Major Birch Pollen Allergen, Bet v 1
    Gieras, Anna
    Cejka, Petra
    Blatt, Katharina
    Focke-Tejkl, Margarete
    Linhart, Birgit
    Flicker, Sabine
    Stoecklinger, Angelika
    Marth, Katharina
    Drescher, Anja
    Thalhamer, Josef
    Valent, Peter
    Majdic, Otto
    Valenta, Rudolf
    JOURNAL OF IMMUNOLOGY, 2011, 186 (09) : 5333 - 5344
  • [26] Dynamic flexibility of a peptide-binding groove of human HLA-DR1 class II MHC molecules: Normal mode analysis of the antigen peptide-class II MHC complex
    Nojima, H
    Takeda-Shitaka, M
    Kurihara, Y
    Kamiya, K
    Umeyama, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (08) : 923 - 928
  • [27] Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and-DR4 molecules and collagen-specific T-cell responses
    Fridkis-Hareli, M
    Rosloniec, EF
    Fugger, L
    Strominger, JL
    HUMAN IMMUNOLOGY, 2000, 61 (07) : 640 - 650
  • [28] Peptide immunotherapy in Fel d 1-sensitized HLA-DR1 transgenic mice is associated with increased IL-10 but independent of TGFbeta and Foxp3 expression
    Campbell, D
    Gronlund, H
    van Hage-Hamsten, M
    Altmann, DM
    Lloyd, CM
    Larché, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S327 - S327
  • [29] Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1
    Zavala-Ruiz, Z
    Sundberg, EJ
    Stone, JD
    DeOliveira, DB
    Chan, IC
    Svendsen, J
    Mariuzza, RA
    Stern, LJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) : 44904 - 44912
  • [30] Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays
    Duquesnoy, Rene J.
    Marrari, Marilyn
    Jelenik, Larry
    Zeevi, Adriana
    Claas, Frans H. J.
    Mulder, Arend
    HUMAN IMMUNOLOGY, 2013, 74 (10) : 1271 - 1279